Novel method to select meaningful outcomes for evaluation in clinical trials

被引:4
|
作者
McLeod, Charlie [1 ,2 ]
Norman, Richard [3 ]
Wood, Jamie [4 ,5 ]
Mulrennan, Siobhain [6 ,7 ]
Morey, Sue [6 ]
Schultz, Andre [8 ,9 ]
Messer, Mitch [10 ]
Spaapen, Kate [11 ]
Stoneham, Matthew [12 ]
Wu, Yue [13 ]
Smyth, Alan [14 ]
Blyth, Christopher [1 ,10 ]
Webb, Steve [15 ,16 ]
Mascaro, Steven [17 ]
Woodberry, Owen [17 ]
Snelling, Tom [13 ,18 ]
机构
[1] Perth Childrens Hosp, Infect Dis, Nedlands, WA, Australia
[2] Telethon Kids Inst, Infect Dis Implementat Res, Nedlands, WA, Australia
[3] Curtin Univ, Sch Populat Hlth, Bentley Campus, Bentley, WA, Australia
[4] Icahn Sch Med Mt Sinai, Abil Res Ctr, Dept Rehabil & Human Performance, New York, NY 10029 USA
[5] Sir Charles Gairdner Hosp, Dept Physiotherapy, Nedlands, WA, Australia
[6] Sir Charles Gairdner Hosp, Resp Med, Nedlands, WA, Australia
[7] Univ Western Australia, Fac Hlth & Med Sci, Perth, WA, Australia
[8] Telethon Kids Inst, Wal Yan Resp Res Ctr, Nedlands, WA, Australia
[9] Perth Childrens Hosp, Dept Resp Med, Nedlands, WA, Australia
[10] Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Nedlands, WA, Australia
[11] Consumer Advocate, Perth, WA, Australia
[12] Consumer Advocate, Melbourne, Vic, Australia
[13] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia
[14] Univ Nottingham, Sch Med, Evidence Based Child Hlth Grp, Nottingham, England
[15] Monash Univ, Sch Populat Hlth & Prevent Med, Clayton, Vic, Australia
[16] St John God Hlth Care, Dept Intens Care Med, Perth, WA, Australia
[17] Bayesian Intelligence, Upwey, Vic, Australia
[18] Menzies Sch Hlth Res, Casuarina, NT, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
cystic fibrosis; paediatric lung disaese; rare lung diseases; respiratory infection; SURROGATE END-POINTS;
D O I
10.1136/bmjresp-2021-000877
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background A standardised framework for selecting outcomes for evaluation in trials has been proposed by the Core Outcome Measures in Effectiveness Trials working group. However, this method does not specify how to ensure that the outcomes that are selected are causally related to the disease and the health intervention being studied. Causal network diagrams may help researchers identify outcomes that are both clinically meaningful and likely to be causally dependent on the intervention, and endpoints that are, in turn, causally dependent on those outcomes. We aimed to (1) develop a generalisable method for selecting outcomes and endpoints in trials and (2) apply this method to select outcomes for evaluation in a trial investigating treatment strategies for pulmonary exacerbations of cystic fibrosis (CF). Methods We conducted a series of online surveys and workshops among people affected by CF. We used a modified Delphi approach to develop a consensus list of important outcomes. A workshop involving domain experts elicited how these outcomes were causally related to the underlying pathophysiological processes. Meaningful outcomes were prioritised based on the extent to which each outcome captured separate rather than common aspects of the underlying pathophysiological process. Results The 10 prioritised outcomes were: breathing difficulty/pain, sputum production/clearance, fatigue, appetite, pain (not related to breathing), motivation/demoralisation, fevers/night sweats, treatment burden, inability to meet personal goals and avoidance of gastrointestinal symptoms. Conclusions This proposed method for selecting meaningful outcomes for evaluation in clinical trials may improve the value of research as a basis for clinical decisions.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Development of a method to involve patients in the determination and appraisal of outcomes in clinical trials
    Charlotte M.W. Gaasterland
    Marijke C. Jansen-van der Weide
    Johanna H. van der Lee
    Trials, 16
  • [32] Clinically Meaningful Gaps Between Clinical Trials and Patient Treatment
    Buchanan, Robert W.
    Carpenter, William T.
    SCHIZOPHRENIA BULLETIN, 2018, 44 (04) : 701 - 702
  • [33] Retina Stability - a meaningful Endpoint in neovascular AMD Clinical Trials?
    Augustin, A. J.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2017, 234 (08) : 2 - 4
  • [35] Developing meaningful public involvement in a cancer clinical trials unit
    Jessica Baillie
    Jim Fitzgibbon
    Natalie Simon
    Annmarie Nelson
    Trials, 16
  • [36] Developing meaningful public involvement in a cancer clinical trials unit
    Baillie, Jessica
    Fitzgibbon, Jim
    Simon, Natalie
    Nelson, Annmarie
    TRIALS, 2015, 16
  • [37] Validating outcomes in clinical trials
    Straube, S.
    15TH WORLD CONGRESS OF PAIN CLINICIANS (WSPC 2012), 2012, : 1 - 2
  • [38] Evaluation of clinical trials
    Ural, Dilek
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2010, 38 : 57 - 64
  • [39] Neuroimaging outcomes for clinical trials
    Frisoni, G. B.
    Caroli, A.
    JOURNAL OF NUTRITION HEALTH & AGING, 2007, 11 (04): : 348 - 352
  • [40] ERDO - a framework to select an appropriate randomization procedure for clinical trials
    Hilgers, Ralf-Dieter
    Uschner, Diane
    Rosenberger, William F.
    Heussen, Nicole
    BMC MEDICAL RESEARCH METHODOLOGY, 2017, 17